chain to loop: cost-aware value-of-information scheduling for cyclic-peptide discovery
Authors/Creators
- 1. BioMate AI
- 2. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston
- 3. Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN
Description
Drug discovery screens candidate molecules through a cascade of assays rather
than a single test — from cheap property predictors through docking, molecular
dynamics and free-energy perturbation to synthesis and a wet-lab measurement
— whose costs differ by orders of magnitude. As these pipelines become
automated, a platform must decide not only which candidate to test next but
which assay to spend the next unit of budget on — a scheduling question that is
usually ignored. What little evidence exists is measured across repeated runs of a
single method rather than across the laboratories or targets to which a result
must generalise. Here we ask whether a cost-aware value-of-information (VOI)
policy can do better: at each step it chooses the candidate-and-assay pair that
most reduces advance-or-kill uncertainty per unit of cost. The preliminary
experimental results are promising. On two real cyclic-peptide discovery cascades
— PAMPA permeability for 715 molecules across 27 laboratories, and 𝐾i binding
affinity for 1,964 compounds across 40 targets — VOI scheduling beat the
standard cascade that runs each candidate from the cheapest assay to the dearest
(with the sealed endpoint assigned the expensive role by construction, a stylised
cost model), raising the cost-weighted top-10 AUC by 0.201 for permeability and
by a positive margin for binding (0.080), each beating a random baseline.
Significance is judged by a cluster bootstrap over whole laboratories and targets
rather than individual molecules — inference to the population of such units
rather than a held-out test on unseen ones. Choosing what to measure next, not
only what to make, turns a fixed validation cascade into an adaptive one — and as
discovery moves toward self-driving laboratories, deciding where to spend each
experiment may come to matter as much as the molecules proposed.
Files
MethodPaperB_VOI_nature-style (3).pdf
Additional details
Dates
- Updated
-
2026-11-10